Our sector specialties include: Consumer; Healthcare; Media; Power & Energy Transition; and Technology. Guggenheim Equity Research analysts average 18 years of Wall Street and industry experience, bringing our clients rich perspectives and deep domain expertise.
Rigorous primary research is central to our approach. Innovation and disruption are constants in the sectors we cover and on-the-ground work keeps our team at the leading edge of trend changes for the benefit of our clients. Our signature research products uncover these findings and include:
The Consumer team covers automotive, e-commerce, hardline and softline retail, and restaurants.
The Healthcare team covers biotechnology, biopharmaceuticals, diagnostics and life sciences tools, and healthcare services.
The Power & Energy Transition team covers energy & industrial technology, power, and utilities.
For access to our research offerings and products, please contact your Guggenheim Securities Sales representative or email GSInfo@guggenheimpartners.com.
Already Registered? View the content library on the research portal (login required).
I&I Spotlight Series – Treg-based Therapies
Senior Managing Directors Whitney Wolfe and Yatin Suneja partake in a Q&A session regarding the future of the Treg-Therapies.
Highlights From the Second Guggenheim Targeted Protein Day
Senior Managing Director Michael Schmidt discusses the key topics from the event.
| Date | Sector | Location | Conference Name |
|---|---|---|---|
| 2/11-2/12 | Healthcare | New York | Emerging Outlook: Biotech Summit 2026 |
| 2/23-2/26 | Healthcare | Telluride | Seventh Annual Healthy Altitudes Summit |
Guggenheim Hosts Second Healthcare Innovation Conference
Guggenheim Securities recently hosted its Second Healthcare Innovation Conference in Boston, bringing together executives from 150 leading private and public biopharma companies and facilitating more than 2,300 meetings. The platform created meaningful knowledge exchange, strategic relationship-building, and dialogue around the future of healthcare innovation. We thank our corporate and investor clients for their participation and thoughtful engagement, which helped drive productive conversations and actionable takeaways.
Seamus Fernandez Joins CNBC to Discuss Market Outlook for the Weight Loss Drug Industry
Global Biopharmaceutical and Biotechnology Equity Research Analyst Seamus Fernandez joined CNBC's "Power Lunch" to discuss his market outlook for the weight loss drug industry.
Michael Morris Joins CNBC to Discuss Outlook for Streaming Bundles
Media & Internet Equity Research Analyst Michael Morris recently joined CNBC to analyze recent industry earnings results and share his outlook for streaming bundles.
